![Rahul Rajan Kaushik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rahul Rajan Kaushik
Directeur Technique/Scientifique/R&D chez
DISC MEDICINE, INC.
Profil
Rahul Rajan Kaushik is Chief Technical Officer at Disc Medicine, Inc. since 2024.
Formerly, Dr. Kaushik was SVP-Technical Operations & Manufacturing at Kyntra Bio, Inc. from 2020 to 2024 and Head-External Manufacturing at Nektar Therapeutics.
Education includes a doctorate from Stanford University and undergraduate and graduate degrees from Indian Institute of Technology Bombay.
Postes actifs de Rahul Rajan Kaushik
| Sociétés | Poste | Début |
|---|---|---|
| DISC MEDICINE, INC. | Directeur Technique/Scientifique/R&D | 23/10/2024 |
Anciens postes connus de Rahul Rajan Kaushik
| Sociétés | Poste | Fin |
|---|---|---|
| KYNTRA BIO, INC. | Directeur Technique/Scientifique/R&D | 01/10/2024 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
Formation de Rahul Rajan Kaushik
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Indian Institute of Technology Bombay
 Indian Institute of Technology Bombay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Disc Medicine, Inc.
 Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
